Perspectives
Nature Reviews Drug Discovery 5, 459-462 (June 2006) | doi:10.1038/nrd2034
Opinion: Impact of genetic diagnostics on drug development strategy
Ryan P. Million1 About the author
Abstract
Innovation in diagnostics will be essential for the successful adoption of personalized medicine and will also have a major impact on the success of drug development strategies. To remain competitive, companies will need to embrace the rapid innovation in the diagnostic market, utilize diagnostic tools concurrently with research and development, and re-invent how new drugs are brought to market. In this article, specific examples of targeted oncology drugs are used to illustrate the general impact of genetic diagnostics on drug development.
Author affiliations
-
Ryan P. Million is at Trinity Partners, LLC, 100 Park Avenue, Suite 1600, New York, New York 10017, USA.
Email: rmillion@trinitypartners.com
Published online 12 May 2006
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
The role of companion diagnostics in the development and use of mutation-targeted cancer therapiesNature Biotechnology Research (01 Aug 2006)
See all 7 matches for Research
